TrialCardiovascular drugs and therapy2013

Grape resveratrol increases serum adiponectin and downregulates inflammatory genes in peripheral blood mononuclear cells: a triple-blind, placebo-controlled, one-year clinical trial in patients with stable coronary artery disease.

João Tomé-Carneiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.